Infectious Disease and Microbiology – Pseudallescheria boydii

Overview

Pseudallescheria boydii is a filamentous fungus (mold) characterized by septate, hyaline hyphae. It has historically also been associated with the name Scedosporium apiospermum, although modern taxonomy distinguishes sexual and asexual forms within the Scedosporium/Pseudallescheria complex.

This environmental mold has a worldwide distribution and can cause both localized and invasive disease. Important manifestations include eumycetoma, pulmonary infection, brain abscess, osteomyelitis, sinusitis, ocular infection, endocarditis, fungal balls, and disseminated infection.

A particularly important clinical feature is that its invasive infections can closely resemble aspergillosis, but P. boydii/Scedosporium is characteristically poorly susceptible or resistant to amphotericin B.

Classification

Genus: Pseudallescheria

Species: Pseudallescheria boydii

Historical/related terminology:

Scedosporium apiospermum

Organism type: Filamentous fungus (mold)

Hyphae: Hyaline and septate

Microbiologic Characteristics

The characteristic morphology includes:

• Septate hyaline hyphae

• Filamentous mold growth

• Fungal aggregates or granules in mycetoma

• Hyaline septate hyphae in invasive hyalohyphomycosis

Because the hyphae may resemble those of Aspergillus, microbiologic identification is important.

High-Yield Microbiology Pattern

Hyaline mold

• ●

Septate hyphae

• ●

Aspergillus-like appearance

• ●

Poor amphotericin B activity

→ Think Pseudallescheria/Scedosporium

Incubation Period

The incubation period is:

Unknown

For mycetoma, infection is generally chronic and slowly progressive following environmental inoculation.

Epidemiology

P. boydii has a:

Worldwide distribution

The organism occurs environmentally in:

• Soil

• Polluted water

• Sewage-contaminated environments

• Organic material

Mycetoma is particularly common in:

Tropical and subtropical regions

Transmission

Localized infection may develop after:

Traumatic inoculation

of contaminated environmental material into:

Skin or subcutaneous tissue

This helps explain the frequent involvement of exposed areas such as:

Feet and hands

Mycetoma

One of the classic manifestations of P. boydii infection is:

MYCETOMA

Mycetoma is a chronic infection involving:

Skin + subcutaneous tissue

and may eventually extend into:

Bone

Classic Mycetoma Triad

The classic clinical triad is:

Tumefaction

• ●

Draining sinus tracts

• ●

Granules in the drainage

→ MYCETOMA

This is one of the most important exam patterns associated with the disease.

Tumefaction

Mycetoma produces a:

Slowly enlarging, tumor-like swelling

The lesion is usually chronic and may progress over a prolonged period.

Draining Sinus Tracts

As infection progresses, multiple:

Sinus tracts

may develop between the infected tissue and skin surface.

These tracts can discharge:

Pus containing characteristic granules

Granules

The granules contain aggregates of the causative organism.

In fungal mycetoma, microscopic examination may demonstrate:

Fungal hyphae within the granules

Recognition and culture of these structures can help identify the causative organism.

High-Yield Mycetoma Pattern

Tropical exposure

• ●

Chronic swelling of foot

• ●

Multiple draining sinuses

• ●

Granules in pus

→ Think MYCETOMA

Eumycetoma vs. Actinomycetoma

Mycetoma can be caused by either:

True fungi

or

Filamentous bacteria

Eumycetoma

Caused by:

Fungi

Examples include:

Pseudallescheria/Scedosporium

and other mycetoma-producing molds.

Actinomycetoma

Caused by filamentous bacteria such as:

Nocardia

and certain other aerobic actinomycetes.

Historically, Actinomyces has also appeared in discussions of mycetoma-like infections.

High-Yield Distinction

Eumycetoma

→ Fungal

Actinomycetoma

→ Bacterial

Both may produce:

Swelling + sinus tracts + granules

Sites of Mycetoma

The most characteristic sites are:

Feet

and

Hands

because these exposed areas are susceptible to traumatic environmental inoculation.

However, infection may occur on:

Any exposed body surface

Madura Foot

Mycetoma involving the foot is classically known as:

Madura foot

The clinical picture is:

Chronic foot swelling

• ●

Draining sinus tracts

• ●

Granules

Osteomyelitis

Chronic infection may extend from soft tissue into:

Underlying bone

resulting in:

Osteomyelitis

Bone involvement is an important complication of advanced mycetoma.

Hyalohyphomycosis

Outside the classic mycetoma syndrome, P. boydii can produce:

Hyalohyphomycosis

This refers to infection caused by molds that demonstrate:

Hyaline, septate hyphae in tissue

Aspergillus-Like Disease

An important diagnostic problem is that invasive P. boydii infection can resemble:

Aspergillus

in terms of:

• Clinical presentation

• Tissue appearance

• Septate hyphal morphology

Therefore:

Septate hyphae in tissue do not automatically mean Aspergillus.

Culture or other organism-specific identification is important.

High-Yield Diagnostic Trap

Septate hyaline hyphae

→ Do not automatically diagnose Aspergillus

If culture identifies:

Pseudallescheria/Scedosporium

the therapeutic implications are important because of differing antifungal susceptibility.

Pulmonary Infection

P. boydii may cause:

Pneumonia

particularly in susceptible patients.

Pulmonary disease can resemble:

Invasive pulmonary aspergillosis

and may occur in patients with underlying lung disease or impaired immunity.

Fungal Ball

The organism can colonize preexisting pulmonary cavities and form:

Fungal balls

This can closely resemble an:

Aspergilloma

High-Yield Pulmonary Pattern

Preexisting lung cavity

• ●

Fungal ball

• ●

Aspergillus-like septate hyphae

→ Consider Scedosporium/Pseudallescheria as well as Aspergillus

Brain Abscess

A particularly serious manifestation is:

Brain abscess

CNS disease can occur following dissemination or particular environmental exposures.

Neurologic manifestations depend on the location and extent of infection.

Near-Drowning Association

An especially important clinical association with Scedosporium apiospermum is:

Near-drowning in contaminated water

followed later by:

Central nervous system infection or brain abscess

This organism can be present in polluted water, making this exposure an important diagnostic clue.

High-Yield CNS Pattern

Near-drowning

• ●

Contaminated/polluted water exposure

• ●

Delayed brain abscess

→ Think Scedosporium apiospermum

Meningitis

The source also identifies:

Meningitis

as a possible manifestation.

CNS infection is serious and may be difficult to treat.

Eye Infections

Ocular manifestations may include:

• Keratitis

• Endophthalmitis

• Other invasive ocular infections

These may follow:

Trauma

or other direct inoculation events.

Sinusitis

P. boydii may cause:

Fungal sinusitis

The clinical and histopathologic appearance may resemble infection caused by other hyaline molds.

Endocarditis

Rarely, the organism may cause:

Endocarditis

This is a serious invasive manifestation and may require combined:

Antifungal therapy + surgical management

depending on the circumstances.

Disseminated Infection

In susceptible patients, P. boydii can cause:

Disseminated fungal infection

with involvement of multiple organs.

Risk is increased in patients with:

Significant immunosuppression

Diagnosis

Diagnosis is based on:

Culture

and

Identification of the organism in tissue biopsy specimens

For mycetoma, examination of:

Granules from draining sinus tracts

is particularly useful.

Examination of Granules

The granular material discharged from mycetoma lesions contains:

Aggregates of fungal elements

Microscopic examination can provide clues to the causative organism.

Culture is needed for more specific identification.

Histopathology

Tissue examination may demonstrate:

Septate hyaline hyphae

However, this appearance can resemble:

Aspergillus

Therefore, morphology alone may not reliably distinguish the two.

Culture

Culture is particularly important because:

Correct identification directly affects treatment

This is especially true when differentiating Scedosporium/Pseudallescheria from Aspergillus.

Treatment

The source emphasizes that treatment data are limited.

Historically, high-dose azoles such as:

• Itraconazole

• Miconazole

• Ketoconazole

were recommended.

For invasive Scedosporium apiospermum/Pseudallescheria boydii infection, voriconazole has become an especially important systemic antifungal option.

Amphotericin B Resistance

One of the most important treatment facts is:

AMPHOTERICIN B IS OFTEN INEFFECTIVE

against P. boydii/S. apiospermum.

This contrasts with many other serious invasive mold infections.

High-Yield Treatment Pattern

Aspergillus-like invasive mold infection

• ●

Septate hyaline hyphae

• ●

Poor response/resistance to amphotericin B

→ Think Scedosporium/Pseudallescheria

Surgical Management

Localized infection may require:

Surgical excision or debridement

This is particularly important for:

• Mycetoma

• Osteomyelitis

• Localized deep infection

• Abscesses

• Infected or necrotic tissue

Thus, management may require:

ANTIFUNGAL THERAPY

• ●

SURGICAL SOURCE CONTROL

Treatment of Mycetoma

Fungal mycetoma can be difficult to eradicate.

Management may require:

• Prolonged antifungal therapy

• Surgical debridement

• Excision of localized lesions

• Management of associated osteomyelitis

Extensive disease may be particularly challenging.

Pseudallescheria/Scedosporium vs. Aspergillus

Both can demonstrate:

Hyaline septate hyphae

and both may cause:

• Pneumonia

• Sinusitis

• CNS infection

• Fungal balls

• Disseminated disease

However:

Aspergillus

→ Classic acute-angle branching septate hyphae

→ Amphotericin B formulations can have activity against some species

Scedosporium apiospermum / Pseudallescheria boydii

→ Can closely mimic Aspergillus

→ Amphotericin B often has poor activity

→ Voriconazole is an important therapeutic agent

→ Notable association with CNS infection after near-drowning

Pseudallescheria vs. Mucorales

Pseudallescheria/Scedosporium

→ Septate, hyaline hyphae

Mucorales

→ Broad, ribbon-like, typically pauciseptate or aseptate hyphae

Thus, the hyphal morphology can help narrow the differential.

Pseudallescheria vs. Nocardia

Both may be associated with:

Mycetoma

However:

Pseudallescheria

→ Fungus

→ Hyaline septate hyphae

→ Eumycetoma

Nocardia

→ Filamentous bacterium

→ Gram-positive branching organism

→ Often weakly acid-fast

→ Actinomycetoma

Prevention

There is no specific vaccine.

General preventive measures include:

• Protecting feet and hands from penetrating environmental trauma

• Wearing footwear in endemic areas

• Cleaning contaminated wounds

• Appropriate management of traumatic injuries

• Avoiding unnecessary exposure of open wounds to contaminated soil or water

High-Yield Mycetoma Pattern

Tropical region

• ●

Chronic painless swelling of foot

• ●

Draining sinus tracts

• ●

Granules

→ Mycetoma

If caused by a hyaline mold such as Pseudallescheria:

→ Eumycetoma

High-Yield Invasive Pattern

Near-drowning in polluted water

• ●

Delayed CNS infection/brain abscess

• ●

Septate hyaline mold

→ Think Scedosporium apiospermum

Exam Essentials

Historical name: Pseudallescheria boydii

Related/currently used name: Scedosporium apiospermum complex

Type: Filamentous fungus (mold)

Hyphae: Hyaline and septate

Distribution: Worldwide

Mycetoma distribution: More common in tropical/subtropical regions

Classic localized disease: Eumycetoma

Classic mycetoma triad: Tumefaction + draining sinuses + granules

Classic site: Foot (Madura foot) and hands

Possible complication: Osteomyelitis

Other infections: Pneumonia, sinusitis, brain abscess, meningitis, ocular infection, endocarditis, fungal balls, and disseminated infection

Important exposure: Near-drowning → CNS infection/brain abscess

Histopathology: Septate hyaline hyphae

Major mimic: Aspergillus

Diagnosis: Culture + tissue biopsy, with examination of mycetoma granules when present

Major treatment clue: Amphotericin B often ineffective

Important systemic agent: Voriconazole

Source-listed azoles: High-dose itraconazole, miconazole, or ketoconazole

Source control: Surgical debridement/excision may be necessary

Key clinical pearl: Pseudallescheria boydii/Scedosporium apiospermum is a hyaline, septate mold that can cause eumycetoma or invasive disease closely resembling aspergillosis. Remember two particularly high-yield clues: chronic swelling with draining sinuses and granules indicates mycetoma, while delayed brain abscess after near-drowning in polluted water strongly suggests Scedosporium. Unlike many invasive molds, it often responds poorly to amphotericin B, making correct identification therapeutically important.

Infectious Disease and Microbiology – Providencia Species

Overview

Providencia species are Gram-negative bacilli within the order Enterobacterales. They are opportunistic pathogens particularly associated with healthcare-associated infections, especially complicated and catheter-associated urinary tract infections.

Important clinical manifestations include UTI, intra-abdominal infection, central venous catheter-related infection, and bacteremia. Providencia can develop substantial antimicrobial resistance, including extended-spectrum β-lactamase (ESBL) and other resistance mechanisms, making culture and susceptibility testing particularly important.

Classification

Genus: Providencia

Important species include:

• Providencia alcalifaciens

• Providencia rettgeri

• Providencia rustigianii

• Providencia stuartii

• Other species

Among these, P. stuartii and P. rettgeri are particularly important in healthcare-associated urinary infections.

Microbiologic Characteristics

Providencia species are generally:

• Gram-negative bacilli

• Facultatively anaerobic

• Members of Enterobacterales

• Motile

• Oxidase negative

• Phenylalanine deaminase positive

• Generally non-lactose fermenting

They are microbiologically related to:

Proteus

and

Morganella

High-Yield Microbiology Pattern

Gram-negative bacillus

• ●

Enterobacterales

• ●

Phenylalanine deaminase positive

• ●

Healthcare-associated UTI

→ Think Providencia

Incubation Period

A specific incubation period is usually not applicable because infection is commonly:

Endogenous or healthcare associated

Disease often develops in patients with underlying medical conditions or invasive devices.

Epidemiology

Providencia is particularly important as a:

Nosocomial pathogen

Risk factors include:

• Prolonged hospitalization

• Long-term care residence

• Chronic urinary catheterization

• Urinary tract abnormalities

• Repeated antimicrobial exposure

• Severe underlying disease

• Invasive medical devices

Providencia stuartii

Providencia stuartii is particularly associated with:

Long-term urinary catheterization

and

Healthcare-associated urinary tract infection

It has historically been an important pathogen in:

Long-term care facilities and chronically catheterized patients

High-Yield Clinical Association

Long-term care patient

• ●

Chronic urinary catheter

• ●

Gram-negative UTI

→ Consider Providencia stuartii

Providencia rettgeri

Providencia rettgeri is another clinically important species associated with:

• Urinary tract infections

• Healthcare-associated infections

• Bacteremia

Like other Providencia species, antimicrobial resistance may complicate treatment.

Urinary Tract Infection

The urinary tract is one of the most important sites of Providencia infection.

Clinical syndromes include:

• Catheter-associated UTI

• Complicated cystitis

• Pyelonephritis

• Urosepsis

The association with:

Indwelling urinary catheters

is particularly important.

Urease Production

Some clinically important Providencia species, particularly P. rettgeri, may produce:

UREASE

Urease breaks down urea and can contribute to:

Urinary alkalinization

and potentially:

Stone formation and catheter encrustation

This provides an important microbiologic connection with Proteus, although the classic urease–struvite association remains strongest with Proteus mirabilis.

Catheter-Associated UTI

Urinary catheters provide:

A surface for bacterial adherence and biofilm formation

and allow organisms to persist within the urinary tract.

Thus:

Chronic catheter

↓

Colonization/biofilm

↓

Persistent or recurrent bacteriuria

↓

Symptomatic UTI

↓

Possible ascending infection

↓

Bacteremia/urosepsis

High-Yield UTI Pattern

Hospitalized or long-term care patient

• ●

Chronic urinary catheter

• ●

Resistant Gram-negative bacillus

→ Think Providencia, particularly P. stuartii

Bacteremia

Providencia species can cause:

Bacteremia

The source may be:

• Urinary tract

• Central venous catheter

• Intra-abdominal infection

• Other invasive infection

Urinary-source bacteremia is particularly important in patients with complicated UTI.

Central Venous Catheter-Related Infection

The source also identifies:

Central venous catheter-related infection

as an important manifestation.

Management should include consideration of:

Catheter source control

in addition to appropriate antimicrobial therapy.

Intra-Abdominal Infection

Providencia may occasionally participate in:

Intra-abdominal infection

These infections can be:

Polymicrobial

and may require antimicrobial coverage beyond Providencia alone.

Abscess or other surgically correctable sources may require:

Drainage or operative source control

Nosocomial Infection

A major epidemiologic characteristic is the organism’s association with:

Healthcare-associated infection

This is clinically important because healthcare-associated isolates are more likely to have been exposed to antimicrobial selection pressure and may demonstrate:

Multidrug resistance

Diagnosis

The principal diagnostic method is:

Culture

Depending on the clinical syndrome, specimens may include:

• Urine

• Blood

• Central-line-associated blood cultures

• Abscess material

• Intra-abdominal specimens

Antimicrobial Susceptibility Testing

Susceptibility testing is particularly important because Providencia may possess or acquire multiple resistance mechanisms.

Therefore:

Identification alone is not sufficient

The isolate’s:

Antimicrobial susceptibility profile

should guide definitive treatment whenever possible.

Antimicrobial Resistance

Providencia species may demonstrate resistance involving:

• β-lactam antibiotics

• Fluoroquinolones

• Aminoglycosides

• Multiple other antimicrobial classes

Some strains can produce:

Extended-spectrum β-lactamases (ESBLs)

and more extensively resistant isolates may possess:

Carbapenemases

or other mechanisms.

ESBL

Extended-spectrum β-lactamases

can hydrolyze many:

Penicillins

and

Extended-spectrum cephalosporins

This is particularly important in healthcare-associated Gram-negative infections.

High-Yield Resistance Pattern

Nosocomial Providencia infection

• ●

Resistance to extended-spectrum cephalosporins

→ Consider ESBL or another β-lactam resistance mechanism

→ Use susceptibility results to guide therapy

Treatment

The source lists:

Meropenem

or

Imipenem

particularly when an ESBL-producing isolate is suspected.

It also lists:

Ciprofloxacin

as a treatment option.

Because susceptibility patterns vary considerably, definitive therapy should be based on:

Culture and antimicrobial susceptibility testing

rather than genus identification alone.

Additional Treatment Options

The source lists:

• Third-generation cephalosporins

• Aztreonam

• Ofloxacin

• Piperacillin–tazobactam

• Aminoglycosides

Whether any of these agents is appropriate depends on:

Documented susceptibility + infection severity + infection site

Important Aminoglycoside Consideration

An important microbiologic feature of Providencia is that susceptibility to individual aminoglycosides can be unpredictable.

In particular, some Providencia species have intrinsic resistance to certain aminoglycosides, so an aminoglycoside should not be assumed to be active without susceptibility information.

Source Control

Antimicrobial therapy alone may be insufficient when infected foreign material or an anatomic abnormality persists.

Important interventions may include:

• Removal or replacement of an unnecessary urinary catheter

• Management of urinary obstruction

• Evaluation of urinary stones

• Management of an infected central venous catheter

• Drainage of an intra-abdominal abscess

High-Yield Treatment Principle

Providencia infection

→ Obtain culture and susceptibility

• ●

Treat with an active antimicrobial

• ●

Correct the underlying catheter/device/anatomic source

Providencia vs. Proteus

Both belong to a related group of Enterobacterales and are:

Phenylalanine deaminase positive

Both may cause:

Urinary tract infection

However:

Proteus mirabilis

→ Famous for swarming motility

→ Strongly urease positive

→ Classic association with struvite/staghorn stones

Providencia

→ Particularly associated with nosocomial and catheter-associated UTI

→ P. stuartii is a classic long-term catheter organism

→ Antimicrobial resistance is an important concern

Providencia vs. Morganella

Providencia, Proteus, and Morganella form an important related group of Enterobacterales.

All may demonstrate:

Phenylalanine deaminase activity

and all can be opportunistic causes of:

Urinary tract and healthcare-associated infection

The specific organism is differentiated by biochemical testing and modern laboratory identification methods.

Providencia vs. E. coli

E. coli

→ Most common cause of community-acquired UTI

→ Common intestinal flora

→ Often lactose fermenting

Providencia

→ Less common overall

→ Particularly associated with healthcare settings

→ Important in chronically catheterized patients

→ Often non-lactose fermenting

→ Multidrug resistance can be prominent

Prevention

Prevention focuses primarily on reducing healthcare-associated infection.

Important measures include:

• Avoid unnecessary urinary catheterization

• Remove urinary catheters as soon as possible

• Maintain appropriate catheter care

• Use strict aseptic technique for central venous catheters

• Remove unnecessary vascular devices

• Follow infection-control precautions

• Use antimicrobials appropriately to reduce resistance selection

High-Yield Clinical Pattern

Long-term care or hospitalized patient

• ●

Chronic urinary catheter

• ●

Complicated UTI

• ●

Multidrug-resistant Gram-negative bacillus

→ Think Providencia, especially P. stuartii

Exam Essentials

Genus: Providencia

Important species: P. alcalifaciens, P. rettgeri, P. rustigianii, and P. stuartii

Type: Gram-negative bacillus

Order: Enterobacterales

Metabolism: Facultatively anaerobic

Oxidase: Negative

Motility: Generally motile

Phenylalanine deaminase: Positive

Related genera: Proteus and Morganella

Incubation: Usually not defined; often endogenous/healthcare associated

Major epidemiology: Nosocomial infection

Classic species: P. stuartii

Classic risk factor: Chronic urinary catheterization

Major infection: Complicated/catheter-associated UTI

Other infections: Intra-abdominal infection, central venous catheter infection, and bacteremia

Urease: Some species, particularly P. rettgeri, may be urease positive

Diagnosis: Culture

Resistance concern: Multidrug resistance and ESBL production; other resistance mechanisms may occur

Source ESBL treatment: Meropenem or imipenem

Source alternative: Ciprofloxacin if susceptible

Additional source agents: Third-generation cephalosporins, aztreonam, ofloxacin, piperacillin–tazobactam, and aminoglycosides

Management principle: Susceptibility-guided therapy + source control

Key clinical pearl: Providencia is a healthcare-associated Gram-negative bacillus that should be remembered particularly in chronically catheterized patients with complicated UTI. P. stuartii is the classic long-term catheter-associated species, while antimicrobial resistance—including ESBL and occasionally more extensive resistance mechanisms—makes culture and susceptibility-guided treatment essential.

Infectious Disease and Microbiology – Prototheca Species

Overview

Prototheca species are unusual unicellular, achlorophyllous algae that can cause a rare human infection known as protothecosis. Although they are algae, they lack chlorophyll and can grow on routine fungal media with a yeast-like appearance, which may lead to confusion with true fungi.

The most characteristic human manifestation is a chronic cutaneous or subcutaneous infection, often presenting as a relatively painless plaque or papulonodular lesion. Olecranon bursitis is another classic presentation. Disseminated disease, including bloodstream infection, peritonitis, and central nervous system infection, occurs mainly in immunocompromised patients.

Classification

Genus: Prototheca

Species listed in the source include:

• Prototheca stagnora

• Prototheca wickerhamii

• Prototheca zopfii

Organism type: Achlorophyllous alga

Disease: Protothecosis

Microbiologic Characteristics

Prototheca species are:

• Unicellular algae

• Achlorophyllous — they lack chlorophyll

• Capable of growing on fungal culture media

• Yeast-like in culture

• Reproduce by endosporulation

The lack of chlorophyll distinguishes Prototheca from typical photosynthetic algae.

High-Yield Microbiology Pattern

Unicellular alga

• ●

No chlorophyll

• ●

Yeast-like growth on fungal media

• ●

Endosporulation

→ Think Prototheca

Reproduction by Endosporulation

One of the most characteristic microbiologic features is:

Endosporulation

The parent cell, or:

Sporangium

develops multiple internal daughter cells known as:

Endospores

These are subsequently released and continue the reproductive cycle.

Morula-Like Appearance

On microscopic examination, the internal arrangement of endospores may produce a characteristic:

Morula-like appearance

or

“Soccer-ball” appearance

This can be a useful diagnostic clue in tissue or culture.

High-Yield Morphology Pattern

Large spherical cell

• ●

Multiple internal endospores

• ●

Morula/soccer-ball appearance

→ Prototheca

Epidemiology

Prototheca organisms are:

Ubiquitous in nature

They have been recovered particularly from:

• Soil

• Sewage

• Contaminated water

• Organic environmental material

Human protothecosis is:

Rare

but cases have been reported worldwide.

Transmission

Human infection is generally considered:

Environmental

rather than a person-to-person disease.

Cutaneous infection may follow environmental inoculation through:

Traumatized or damaged skin

Risk Factors

Although infection can occasionally occur in otherwise healthy individuals, more severe disease is associated with:

• Immunosuppression

• Malignancy

• Corticosteroid therapy

• Organ transplantation

• Other states of impaired host defense

Localized cutaneous infection and olecranon bursitis may occur without profound systemic immunosuppression.

Cutaneous Protothecosis

The best-described clinical syndrome is:

Skin and soft tissue infection

A characteristic lesion is:

Single + painless + plaque or papulonodular lesion

The lesion may subsequently:

Ulcerate

Clinical Appearance

Cutaneous disease may present with:

• Plaques

• Papules

• Nodules

• Papulonodular lesions

• Ulceration

• Chronic localized inflammation

The course is often:

Chronic and slowly progressive

rather than acutely toxic.

High-Yield Clinical Pattern

Environmental exposure

• ●

Chronic painless plaque/papulonodule

• ●

Occasional ulceration

• ●

Achlorophyllous algae in tissue

→ Think cutaneous protothecosis

Olecranon Bursitis

Another particularly characteristic manifestation is:

Olecranon bursitis

This involves inflammation and infection of the bursa overlying the:

Elbow

The association between Prototheca and chronic olecranon bursitis is sufficiently characteristic to be an important exam clue.

High-Yield Bursitis Pattern

Chronic olecranon bursitis

• ●

Environmental exposure or trauma

• ●

Unusual yeast-like organism

→ Consider Prototheca

Peritonitis

Rare cases of:

Peritonitis

have been reported in patients receiving:

Continuous ambulatory peritoneal dialysis (CAPD)

The peritoneal dialysis catheter provides an opportunity for an environmental organism to enter the peritoneal cavity.

High-Yield Dialysis Pattern

Peritoneal dialysis

• ●

Unusual persistent peritonitis

• ●

Yeast-like organism on fungal culture

→ Consider Prototheca

Meningitis

The source reports rare cases of:

Meningitis

particularly in patients with:

Advanced immunosuppression, including historically patients with AIDS.

Central nervous system disease is an uncommon manifestation of disseminated protothecosis.

Algaemia

Bloodstream infection with Prototheca has been described and may be called:

Algaemia

This manifestation is particularly associated with:

Immunocompromised hosts

and may indicate disseminated infection.

High-Yield Invasive Disease Pattern

Immunocompromised patient

• ●

Unusual yeast-like organism in blood

• ●

Organism actually identified as an achlorophyllous alga

→ Think Prototheca

Diagnosis

The principal diagnostic methods are:

Culture

and

Histopathologic examination of affected tissue

Because Prototheca grows on fungal media, it may initially resemble a yeast.

Culture

Prototheca species can grow on:

Routine fungal culture media

This characteristic contributes to their potential confusion with fungal organisms.

Species identification may require further microbiologic evaluation.

Histopathology

Biopsy of a cutaneous lesion may demonstrate:

Characteristic spherical organisms containing internal endospores

The presence of:

Multiple endospores within a sporangium

is an important morphologic clue.

Diagnostic Pattern

Chronic cutaneous lesion

• ●

Biopsy

• ●

Spherical sporangia containing multiple endospores

→ Prototheca

Differential Diagnosis

Because Prototheca can resemble yeast in culture or tissue, the differential may include:

• Fungal infection

• Chronic bacterial infection

• Other environmental organisms

• Noninfectious inflammatory lesions

Recognition of the characteristic:

Endosporulating sporangia

helps establish the diagnosis.

Prototheca vs. Yeast

Prototheca

→ Alga

→ Lacks chlorophyll

→ Yeast-like growth

→ Endosporulation

→ Sporangia containing multiple daughter cells

True yeast

→ Fungus

→ Commonly reproduces through budding or fission depending on species

→ Does not have the characteristic Prototheca endosporulating morphology

Prototheca vs. Chlorella

Both are algae, but:

Prototheca

→ Lacks chlorophyll

→ Nonphotosynthetic

→ Can cause human infection

Chlorella

→ Contains chlorophyll

→ Photosynthetic

Thus:

Prototheca = achlorophyllous alga

is the key distinction.

Treatment

The source lists:

Amphotericin B

as the principal treatment for protothecosis.

This is particularly important for:

Severe or disseminated disease

Additional Treatment

The source lists several azole antifungal agents:

• Itraconazole

• Ketoconazole

• Posaconazole

• Voriconazole

Despite Prototheca being an alga rather than a fungus, several conventional antifungal agents can have activity against it.

Treatment Considerations

Treatment should be individualized according to:

• Site of infection

• Severity

• Species

• Host immune status

• Susceptibility when available

Because protothecosis is rare, clinical experience is considerably more limited than for common fungal infections.

Surgical Management

Localized disease may sometimes benefit from:

Surgical excision or debridement

This can be particularly relevant for:

• Localized cutaneous lesions

• Olecranon bursitis

Thus, treatment may involve:

ANTIMICROBIAL THERAPY

• ●

SURGICAL SOURCE CONTROL

when appropriate.

Prevention

There is no specific vaccine or chemoprophylaxis.

General preventive measures include:

• Appropriate wound care

• Avoiding contamination of damaged skin

• Proper care of peritoneal dialysis equipment

• Appropriate catheter hygiene

• Infection-control practices in immunocompromised patients

High-Yield Clinical Pattern

Chronic painless skin plaque/nodule

or

Olecranon bursitis

• ●

Environmental exposure

• ●

Yeast-like growth on fungal media

• ●

Morula-like sporangia containing endospores

→ Think Prototheca

Exam Essentials

Genus: Prototheca

Important species: P. wickerhamii, P. zopfii, and P. stagnora

Organism: Unicellular achlorophyllous alga

Chlorophyll: Absent

Culture: Grows on fungal media with a yeast-like appearance

Reproduction: Endosporulation

Characteristic morphology: Sporangia containing multiple endospores

Classic appearance: Morula/soccer-ball pattern

Reservoir: Soil, sewage, water, and environmental organic material

Distribution: Worldwide

Disease: Protothecosis

Most characteristic infection: Cutaneous/soft tissue disease

Classic skin lesion: Painless plaque or papulonodular lesion, sometimes ulcerated

Classic focal association: Olecranon bursitis

Dialysis association: Peritonitis in peritoneal dialysis patients

Immunocompromised hosts: May develop disseminated infection, meningitis, or algaemia

Diagnosis: Culture + histopathology

Source treatment: Amphotericin B

Additional source treatments: Itraconazole, ketoconazole, posaconazole, or voriconazole

Localized disease: Surgical excision/debridement may sometimes be useful

Key clinical pearl: Prototheca is not a true fungus—it is an achlorophyllous alga that nevertheless grows with a yeast-like appearance on fungal media. The classic diagnostic combination is a chronic painless cutaneous plaque or olecranon bursitis with characteristic spherical sporangia containing multiple internal endospores, producing a morula or “soccer-ball” appearance.

Infectious Disease and Microbiology – Propionibacterium Species

Overview

Propionibacterium species are anaerobic Gram-positive bacilli that normally colonize human skin. The most clinically important species historically known as Propionibacterium acnes is now classified as Cutibacterium acnes.

These organisms are best known for their association with acne vulgaris and with indolent infections involving implanted or prosthetic material, particularly shoulder prostheses, cerebrospinal fluid shunts, prosthetic heart valves, and neurosurgical devices.

Classification

Historical genus: Propionibacterium

Important historical species: Propionibacterium acnes

Current terminology:

Propionibacterium acnes

→

Cutibacterium acnes

Organism type: Gram-positive bacillus

Taxonomy Update

The source lists:

P. ances

This appears to refer to:

P. acnes

The organism has subsequently been reclassified as:

Cutibacterium acnes

Therefore, the important modern name to remember is:

Cutibacterium acnes

Microbiologic Characteristics

C. acnes is generally:

• Gram-positive

• Bacillary or pleomorphic in morphology

• Anaerobic to aerotolerant

• Slow growing

• Non-spore-forming

• Part of normal skin flora

Its slow growth and normal presence on skin create an important diagnostic challenge:

Contaminant or true pathogen?

High-Yield Microbiology Pattern

Slow-growing Gram-positive bacillus

• ●

Normal skin flora

• ●

Prosthetic material

• ●

Indolent infection

→ Think Cutibacterium acnes

Incubation Period

The incubation period is:

Unknown

Most infections are:

Endogenous

and originate from the patient’s own skin microbiota.

This is especially important when organisms are introduced into deeper tissues during:

Surgery or implantation of prosthetic material

Epidemiology

Cutibacterium species are common components of:

Normal human skin flora

C. acnes particularly inhabits:

Sebaceous follicles

which helps explain its association with acne.

Pathogenesis

Two major clinical patterns should be remembered:

Sebaceous follicle colonization

→ Inflammation

→ Acne

and

Skin flora introduced during surgery

→ Adherence to implanted material

→ Biofilm formation

→ Chronic prosthetic/device infection

Biofilm Formation

An important characteristic of C. acnes is its ability to form:

Biofilms

on foreign material.

Biofilms allow organisms to:

• Adhere to prosthetic surfaces

• Persist despite host defenses

• Produce slowly progressive infection

• Become difficult to eradicate with antibiotics alone

This explains the organism’s strong association with:

Prosthetic and implanted-device infections

Acne Vulgaris

C. acnes is strongly associated with:

Acne vulgaris

The organism colonizes sebaceous follicles and participates in the inflammatory process associated with acne.

However, acne is multifactorial, involving more than bacterial colonization alone.

Important factors include:

• Follicular obstruction

• Sebum production

• Hormonal influences

• C. acnes

• Host inflammatory responses

High-Yield Acne Pattern

Sebaceous follicle

• ●

Comedones/inflammatory acne

• ●

Cutibacterium acnes

→ Acne vulgaris

Prosthetic Joint Infection

A major invasive manifestation is:

Prosthetic joint infection

C. acnes is especially important in:

Shoulder arthroplasty

and other orthopedic implants.

These infections may be relatively:

Indolent

rather than presenting with dramatic acute sepsis.

Shoulder Association

One of the strongest exam associations is:

Shoulder prosthesis

• ●

Slow, indolent postoperative infection

• ●

Slow-growing Gram-positive bacillus

→ Think Cutibacterium acnes

Clinical Presentation of Prosthetic Joint Infection

Possible manifestations include:

• Persistent joint pain

• Stiffness

• Reduced function

• Prosthetic loosening

• Subtle inflammatory findings

Fever and marked systemic illness may be absent.

This relatively subtle presentation can delay diagnosis.

CSF Shunt Infection

C. acnes can cause infections involving:

Cerebrospinal fluid shunts

The organism may adhere to the implanted device and produce:

Chronic or indolent shunt infection

Post-Neurosurgical Meningitis

The source also describes:

Meningitis following neurosurgical procedures

particularly in association with:

• Neurosurgical devices

• CSF shunts

• Other implanted material

Because the organism is slow growing, cultures may require appropriate incubation.

Endocarditis

C. acnes may cause:

Endocarditis

particularly when:

Prosthetic cardiac material

is present.

Prosthetic valve endocarditis may have a relatively indolent clinical course.

High-Yield Endocarditis Pattern

Prosthetic valve

• ●

Indolent endocarditis

• ●

Slow-growing skin-flora Gram-positive bacillus

→ Consider Cutibacterium acnes

Brain Abscess

The source also reports:

Brain abscess

as a possible manifestation, especially in clinical settings involving neurosurgery or implanted material.

Management may require:

Antimicrobial therapy

plus

Surgical drainage/source control

depending on the clinical situation.

Bacteremia

C. acnes can be recovered from:

Blood cultures

However, interpretation requires caution because the organism is:

Normal skin flora

and can contaminate blood cultures during collection.

Contaminant vs. True Pathogen

This is one of the most important clinical principles for C. acnes.

A positive culture may represent:

CONTAMINATION

or

TRUE INFECTION

Findings Supporting True Infection

True infection becomes more likely with:

• Multiple positive cultures

• Repeated isolation of the same organism

• Isolation from deep tissue surrounding a prosthesis

• Compatible clinical findings

• Prosthetic or implanted material

• Evidence of hardware loosening or infection

• Recovery from a normally sterile operative specimen

High-Yield Diagnostic Pattern

Cutibacterium in one blood culture

→ Could represent skin contamination

but

Repeated positive deep cultures + prosthetic material + compatible symptoms

→ Strongly consider true infection

Diagnosis

The principal diagnostic method is:

Culture

Because the organism grows relatively slowly and prefers anaerobic conditions, appropriate culture techniques are important.

Anaerobic Culture

Specimens should be obtained from:

• Deep tissue

• Prosthetic material

• Joint specimens

• CSF

• Blood

• Abscess material

Appropriate:

Anaerobic culture

and sufficient incubation time improve detection.

Diagnostic Challenge

C. acnes may be overlooked because:

It grows slowly

and

It is frequently assumed to be a contaminant

Therefore, clinical context is essential when determining whether a positive culture is significant.

Treatment of Acne

The source lists:

Tetracycline

or

Macrolide

therapy.

For acne, antimicrobial therapy is only one part of treatment, and modern management depends on acne severity and generally aims to limit unnecessary antibiotic exposure and resistance.

Treatment of Invasive Infection

Treatment of invasive C. acnes infection differs from routine acne therapy.

Management depends on:

• Infection site

• Presence of prosthetic material

• Antimicrobial susceptibility

• Severity

• Ability to remove or revise infected hardware

Because prosthetic infections involve biofilms, antimicrobial therapy alone may not always be sufficient.

Source Control

For device-associated disease, an important management principle is:

ANTIBIOTICS

• ●

DEVICE/SURGICAL SOURCE CONTROL

Depending on the infection, this may involve:

• Prosthesis revision

• Removal or replacement of an infected CSF shunt

• Debridement

• Drainage of an abscess

• Management of infected cardiac prosthetic material

Additional Antimicrobial Agents

The source lists:

• Trimethoprim–sulfamethoxazole

• Vancomycin

as additional treatment options.

Definitive treatment for serious invasive disease should be based on the:

Site of infection, susceptibility profile, and presence of prosthetic material.

Metronidazole Resistance

A particularly important microbiologic treatment clue is:

Cutibacterium acnes is resistant to metronidazole.

This is noteworthy because metronidazole is active against many anaerobic bacteria.

Therefore:

Anaerobic organism ≠ automatically susceptible to metronidazole

High-Yield Resistance Pattern

Anaerobic Gram-positive bacillus

• ●

Cutibacterium acnes

→ Metronidazole resistance

Prevention

Because many invasive infections are associated with surgical implantation of devices, prevention emphasizes:

Good antiseptic technique during surgery

This is particularly important because C. acnes normally resides within:

Sebaceous follicles of the skin

and can potentially contaminate the operative field.

Propionibacterium/Cutibacterium vs. Corynebacterium

Both may appear as:

Gram-positive bacilli

and both are associated with:

Skin flora

However:

Cutibacterium acnes

→ Anaerobic/aerotolerant

→ Slow growing

→ Acne

→ Strong association with prosthetic shoulder infection

Corynebacterium

→ Generally aerobic or facultative

→ Characteristic coryneform morphology

→ Includes both normal skin flora and important pathogens

Cutibacterium vs. Staphylococcus epidermidis

Both are important causes of:

Prosthetic-device infection

and both can form:

Biofilms

Cutibacterium acnes

→ Gram-positive bacillus

→ Slow-growing anaerobic/aerotolerant organism

→ Particularly associated with shoulder prostheses

Staphylococcus epidermidis

→ Gram-positive coccus

→ Coagulase-negative staphylococcus

→ Major cause of infections involving many types of indwelling devices

High-Yield Clinical Pattern

Shoulder arthroplasty

• ●

Chronic pain or prosthetic dysfunction

• ●

Minimal systemic inflammation

• ●

Slow-growing anaerobic Gram-positive bacillus

→ Think Cutibacterium acnes

Exam Essentials

Historical genus: Propionibacterium

Current important genus: Cutibacterium

Historical species: Propionibacterium acnes

Current name: Cutibacterium acnes

Type: Gram-positive bacillus

Growth: Slow-growing, anaerobic/aerotolerant

Normal habitat: Skin, particularly sebaceous follicles

Incubation: Unknown; invasive infections are usually endogenous

Classic superficial association: Acne vulgaris

Major invasive association: Prosthetic/device infection

Classic orthopedic association: Shoulder arthroplasty infection

Other device infections: CSF shunts and prosthetic cardiac material

Other diseases: Post-neurosurgical meningitis, brain abscess, bacteremia, endocarditis

Virulence feature: Biofilm formation

Diagnosis: Culture, often requiring anaerobic conditions and adequate incubation

Diagnostic challenge: Distinguishing contamination from true infection

Source acne treatment: Tetracycline or macrolide

Additional source agents: TMP-SMX and vancomycin

Important resistance: Metronidazole resistant

Device infection principle: Antimicrobial therapy + appropriate source control

Prevention: Careful surgical skin antisepsis and aseptic technique

Key clinical pearl: The organism historically called Propionibacterium acnes is now Cutibacterium acnes. Although it is common normal skin flora and may contaminate cultures, it is an important true pathogen in indolent prosthetic and device-associated infections—particularly shoulder arthroplasty infections. Its ability to form biofilms helps explain persistent hardware-associated disease, and a particularly useful antimicrobial clue is its resistance to metronidazole.

Infectious Disease and Microbiology – Prions

Overview

Prions are unusual infectious agents composed primarily of abnormally folded protein rather than conventional microorganisms. Unlike bacteria, viruses, fungi, and parasites, prions contain no known nucleic acid genome yet are capable of transmitting disease by inducing normally folded host proteins to adopt an abnormal conformation.

Prion diseases are collectively known as transmissible spongiform encephalopathies (TSEs). They are characterized by very long incubation periods, progressive neurodegeneration, spongiform changes in the brain, minimal inflammatory response, and ultimately death.

Classification

Genus: Not applicable

Species: Not applicable

Agent: Proteinaceous infectious particle (prion)

Major target organ: Central nervous system

Prions are fundamentally different from conventional infectious organisms because they lack:

DNA

and

RNA

Microbiologic Characteristics

Prions consist of an abnormal form of a host protein known as:

Prion protein (PrP)

The normal cellular form is commonly designated:

PrPᶜ

The abnormal disease-associated form has traditionally been designated:

PrPˢᶜ

The abnormal protein can promote conformational conversion of normal prion protein into additional abnormal molecules.

Basic Pathogenesis

Normal PrPᶜ

↓

Contact with abnormal prion protein

↓

Protein misfolding

↓

Conversion to abnormal prion conformation

↓

Accumulation and propagation of abnormal protein

↓

Neuronal dysfunction and degeneration

↓

Spongiform encephalopathy

High-Yield Microbiology Pattern

Infectious protein

• ●

No DNA or RNA

• ●

Progressive neurodegeneration

• ●

Spongiform brain changes

→ Think PRION DISEASE

Incubation Period

Prion diseases characteristically have:

Very long incubation periods

The interval between acquisition and clinical disease may extend for:

Years or even decades

depending on the specific prion disease and route of acquisition.

Once neurologic manifestations become clinically apparent, however, many prion diseases progress relentlessly.

Pathology

The characteristic neuropathologic process includes:

• Spongiform degeneration

• Neuronal loss

• Accumulation of abnormal prion protein

• Gliosis

• Minimal or absent conventional inflammatory response

The microscopic vacuolation gives affected brain tissue a:

Sponge-like appearance

hence the term:

Spongiform encephalopathy

Important Pathology Pattern

Rapid or progressive neurologic deterioration

• ●

Spongiform degeneration

• ●

Scant inflammatory response

→ Strongly suggests prion disease

Major Human Prion Diseases

Important human prion diseases include:

• Creutzfeldt–Jakob disease (CJD)

• Variant Creutzfeldt–Jakob disease (vCJD)

• Kuru

• Gerstmann–Sträussler–Scheinker syndrome (GSS)

• Fatal familial insomnia (FFI)

Human prion diseases can arise through:

Sporadic

Inherited

or

Acquired

mechanisms.

Sporadic Creutzfeldt–Jakob Disease

Sporadic CJD is the most common form of human prion disease.

It occurs without an identifiable external exposure or inherited pathogenic variant.

Typical manifestations include:

• Rapidly progressive dementia

• Myoclonus

• Ataxia

• Behavioral or cognitive changes

• Visual disturbances

• Pyramidal or extrapyramidal abnormalities

• Progression to severe neurologic disability

Classic CJD Pattern

Rapidly progressive dementia

• ●

Myoclonus

• ●

Ataxia

• ●

Characteristic MRI/EEG or CSF findings

→ Think Creutzfeldt–Jakob disease

Familial Prion Disease

Some prion diseases result from pathogenic variants involving:

PRNP

the gene encoding prion protein.

Inherited forms include:

• Familial CJD

• Gerstmann–Sträussler–Scheinker syndrome

• Fatal familial insomnia

Variant Creutzfeldt–Jakob Disease

Variant CJD (vCJD) became a major public health concern because of its association with exposure to the agent responsible for:

Bovine spongiform encephalopathy (BSE)

also known as:

“Mad cow disease.”

Variant CJD is distinct from the much more common sporadic form of CJD.

High-Yield Association

Bovine spongiform encephalopathy

→ Human exposure

→ Variant Creutzfeldt–Jakob disease

Kuru

Kuru is an acquired human prion disease historically identified among the Fore people of Papua New Guinea.

Transmission was associated with ritual mortuary practices involving consumption of tissues from deceased individuals.

The disease became a landmark example demonstrating the:

Transmissibility of prion disease

Gerstmann–Sträussler–Scheinker Syndrome

Gerstmann–Sträussler–Scheinker syndrome (GSS) is a rare:

Inherited prion disease

It typically produces progressive neurologic deterioration, often with prominent:

Cerebellar ataxia

and later cognitive decline.

Fatal Familial Insomnia

Fatal familial insomnia (FFI) is an inherited prion disorder characterized by prominent involvement of the:

Thalamus

The syndrome includes progressively severe:

Insomnia

along with autonomic and neurologic abnormalities.

The source’s description of:

“Insomnia secondary to thalamic destruction”

corresponds particularly well to this disorder.

High-Yield Pattern

Progressive severe insomnia

• ●

Autonomic dysfunction

• ●

Thalamic degeneration

• ●

Family history

→ Think Fatal familial insomnia

Clinical Course

Despite differences between individual prion diseases, the overall pattern is:

Long incubation

↓

Clinical neurologic manifestations begin

↓

Progressive neuronal degeneration

↓

Worsening cognitive and motor dysfunction

↓

Severe neurologic disability

↓

Death

Prion diseases are currently considered progressive and fatal.

Inflammatory Response

Unlike many infectious diseases, prion disease generally produces:

Little conventional inflammatory response

This is an important pathologic characteristic.

Thus:

Profound neurodegeneration

can occur despite:

Scant inflammation

Diagnosis

Modern diagnosis of suspected prion disease uses a combination of:

• Clinical presentation

• Brain MRI

• Cerebrospinal fluid testing

• EEG in appropriate cases

• Definitive neuropathologic evaluation when available

CSF RT-QuIC

An especially important modern diagnostic test is:

RT-QuIC

(real-time quaking-induced conversion)

This assay detects the ability of abnormal prion protein in a patient’s specimen to induce conformational changes in substrate prion protein.

CSF RT-QuIC has become an important test for supporting the diagnosis of:

Sporadic CJD

High-Yield Diagnostic Update

Suspected CJD

→ MRI brain

• ●

CSF RT-QuIC

with other clinical and laboratory findings used to establish diagnostic probability.

CSF 14-3-3 Protein

The source lists:

CSF 14-3-3 protein

as a diagnostic finding.

Elevated CSF 14-3-3 can support the diagnosis in an appropriate clinical setting, but it reflects:

Rapid neuronal injury

and is therefore not specific for prion disease.

It can be elevated in other neurologic disorders associated with extensive neuronal damage.

MRI

Brain MRI is extremely useful in suspected CJD.

Characteristic abnormalities may involve:

Cerebral cortex

and

Basal ganglia

with diffusion abnormalities being particularly important.

A classic MRI description in sporadic CJD is:

Cortical ribboning

High-Yield MRI Pattern

Rapidly progressive dementia

• ●

Myoclonus

• ●

Cortical ribboning on diffusion-weighted MRI

→ Strongly consider CJD

EEG

EEG may demonstrate characteristic abnormalities in some patients with sporadic CJD, classically:

Periodic sharp-wave complexes

However, EEG findings are not present in every patient and are interpreted together with MRI, CSF, and clinical findings.

Direct Visualization

Older descriptions may emphasize direct visualization of prion-associated material by:

Electron microscopy

However, electron microscopy is not the routine modern diagnostic approach for suspected CJD.

Modern evaluation relies much more heavily on:

MRI + CSF RT-QuIC + clinical findings

with neuropathology providing definitive confirmation in appropriate circumstances.

Neuropathology

Brain tissue examination may demonstrate:

• Spongiform change

• Neuronal loss

• Gliosis

• Abnormal prion protein deposition

Detection of disease-associated prion protein can provide strong diagnostic evidence.

Treatment

There is currently:

No established curative treatment

for human prion diseases.

Management is primarily:

Supportive and palliative

Supportive Management

Care may include management of:

• Myoclonus

• Pain or discomfort

• Psychiatric or behavioral manifestations

• Sleep disturbances

• Nutritional needs

• Mobility impairment

• Progressive neurologic disability

Because disease is progressive, supportive care and planning become increasingly important.

Infection-Control Importance

Prions are unusually resistant to many conventional:

Disinfection and sterilization procedures

This is especially relevant for instruments that contact:

High-infectivity nervous system tissues

Standard sterilization procedures may not be sufficient under circumstances involving suspected prion contamination, so specialized infection-control protocols are required.

Prions vs. Viruses

Prions

→ Protein only

→ No known DNA or RNA genome

→ Propagate through protein conformational conversion

→ Cause spongiform neurodegeneration

→ Extremely long incubation possible

Viruses

→ Contain DNA or RNA

→ Encode viral genetic information

→ Replicate using host-cell machinery

→ Produce a much broader spectrum of disease

CJD vs. Alzheimer Disease

Creutzfeldt–Jakob disease

→ Usually rapidly progressive cognitive decline

→ Myoclonus common

→ Ataxia may occur

→ Characteristic MRI abnormalities

→ CSF RT-QuIC may be positive

→ Progression often occurs over months

Alzheimer disease

→ Usually slowly progressive over years

→ Memory impairment prominent early

→ Myoclonus is not a typical early feature

→ Different pathologic protein abnormalities

Thus, the speed of progression is an important clinical clue.

CJD vs. Autoimmune Encephalitis

Both can cause:

Rapidly progressive cognitive and neurologic deterioration

However, autoimmune encephalitis is particularly important in the differential because some forms are:

Potentially treatable

Therefore, suspected CJD requires careful evaluation for alternative causes of rapidly progressive dementia.

Major Prion Disease Associations

Sporadic CJD

→ Most common human prion disease

Variant CJD

→ Associated with BSE

Kuru

→ Historical ritual exposure in Papua New Guinea

Gerstmann–Sträussler–Scheinker syndrome

→ Inherited, often prominent ataxia

Fatal familial insomnia

→ Inherited, prominent insomnia and thalamic degeneration

High-Yield Clinical Pattern

Rapidly progressive dementia

• ●

Myoclonus

• ●

Ataxia

• ●

Cortical ribboning on MRI

• ●

Positive CSF RT-QuIC

→ Think CREUTZFELDT–JAKOB DISEASE

Exam Essentials

Agent: Prion

Composition: Abnormally folded proteinaceous infectious material

Nucleic acid: Absent

Mechanism: Induces misfolding of normal host prion protein

Disease group: Transmissible spongiform encephalopathies

Incubation: Usually very long—potentially years to decades

Target: Central nervous system

Pathology: Spongiform degeneration + neuronal loss + gliosis

Inflammation: Characteristically minimal

Course: Progressive and ultimately fatal

Most common human prion disease: Sporadic CJD

CJD clue: Rapidly progressive dementia + myoclonus

Important MRI clue: Cortical ribboning

Important modern CSF test: RT-QuIC

Older/supportive CSF marker: 14-3-3 protein

Classic EEG: Periodic sharp-wave complexes

BSE association: Variant CJD

Papua New Guinea association: Kuru

Inherited ataxic syndrome: Gerstmann–Sträussler–Scheinker syndrome

Thalamic degeneration + insomnia: Fatal familial insomnia

Treatment: No established curative therapy; supportive care

Infection control: Prions have unusual resistance to conventional decontamination procedures

Key clinical pearl: Prions are infectious misfolded proteins that contain no nucleic acid yet propagate by inducing abnormal folding of normal host prion protein. The classic clinical syndrome is a rapidly progressive, fatal neurodegenerative disorder with spongiform brain changes and minimal inflammation; for sporadic CJD, high-yield modern diagnostic clues include cortical ribboning on MRI and a positive CSF RT-QuIC assay.

Infectious Disease and Microbiology – Plesiomonas shigelloides

Overview

Plesiomonas shigelloides is a Gram-negative bacillus found primarily in freshwater environments and soil. Human infection is most commonly associated with gastroenteritis, particularly after exposure to contaminated water or food, and it is recognized as a potential cause of traveler’s diarrhea.

Most intestinal infections are mild and self-limited, but some patients develop an inflammatory or dysentery-like illness with bloody diarrhea, fever, malaise, and fecal leukocytes. Rarely, P. shigelloides causes invasive extraintestinal disease, including bacteremia, soft tissue infection, bone and joint infection, and meningitis.

Classification

Genus: Plesiomonas

Species: Plesiomonas shigelloides

Organism type: Gram-negative bacillus

Microbiologic Characteristics

P. shigelloides is a:

• Gram-negative bacillus

• Facultatively anaerobic organism

• Oxidase-positive bacterium

• Motile organism

• Freshwater-associated enteric pathogen

It is commonly grouped clinically with other water-associated Gram-negative organisms that can produce gastrointestinal disease.

High-Yield Microbiology Pattern

Gram-negative bacillus

• ●

Freshwater exposure

• ●

Acute diarrhea

→ Consider Plesiomonas shigelloides

Incubation Period

The precise incubation period is:

Not clearly established

Evidence from cases of traveler’s diarrhea suggests that symptoms generally develop after a:

Short incubation period of several days

following exposure.

Epidemiology

P. shigelloides is widely distributed in:

Freshwater

and

Soil

It can also be associated with aquatic environments and animals.

Human infection is generally acquired through environmental or food-related exposure rather than sustained person-to-person transmission.

Transmission

Gastrointestinal infection is associated with ingestion of:

• Contaminated water

• Contaminated food

• Raw or inadequately cooked aquatic foods in some settings

Exposure during international travel may lead to:

Traveler’s diarrhea

High-Yield Exposure Pattern

Recent travel

• ●

Freshwater or contaminated food/water exposure

• ●

Acute diarrhea

→ Consider Plesiomonas shigelloides

Gastroenteritis

The most common clinical manifestation is:

Acute gastroenteritis

Disease severity varies considerably.

Some patients develop:

Mild, watery, self-limited diarrhea

while others develop a more inflammatory illness.

Mild Diarrheal Disease

Uncomplicated infection may present with:

• Watery diarrhea

• Abdominal discomfort or cramping

• Nausea

• Malaise

Most mild infections resolve without specific antimicrobial therapy.

Severe or Dysentery-Like Disease

More severe P. shigelloides gastroenteritis may produce:

Bloody diarrhea

associated with:

• Fever

• Malaise

• Abdominal symptoms

• White blood cells in the stool

The presence of blood and fecal leukocytes suggests an:

Inflammatory diarrheal syndrome

High-Yield Clinical Pattern

Traveler

• ●

Acute diarrhea

• ●

Blood and fecal leukocytes

• ●

Freshwater/environmental exposure

→ Consider Plesiomonas shigelloides

Traveler’s Diarrhea

P. shigelloides is one recognized cause of:

Traveler’s diarrhea

Although other organisms are considerably more common, Plesiomonas should be considered when the epidemiologic history includes:

Travel + contaminated food/water + acute gastroenteritis

Extraintestinal Infection

Although gastrointestinal disease is the major manifestation, P. shigelloides can occasionally produce:

Invasive extraintestinal infections

These are much less common than diarrhea.

Bacteremia

Rarely, the organism may enter the bloodstream and cause:

Bacteremia

Systemic infection is more concerning in vulnerable patients and may require antimicrobial treatment.

Skin and Subcutaneous Tissue Infection

The source also reports:

Skin and subcutaneous tissue infections

These may be particularly relevant when damaged tissue is exposed to contaminated environmental water.

Septic Arthritis and Osteomyelitis

Rare musculoskeletal manifestations include:

Septic arthritis

and

Osteomyelitis

These invasive infections require:

Systemic antimicrobial therapy

and may also require drainage or other source-control procedures.

Other Rare Infections

Additional reported manifestations include:

• Cholecystitis

• Endophthalmitis

• Meningitis

These infections are uncommon but demonstrate that P. shigelloides can occasionally behave as an invasive pathogen outside the gastrointestinal tract.

Neonatal Meningitis

One of the most important severe manifestations is:

Meningitis in neonates

Although rare, neonatal P. shigelloides meningitis can be a serious invasive infection.

High-Yield Severe Disease Pattern

Neonate

• ●

Gram-negative bacillary meningitis

• ●

Possible environmental/water-associated organism

→ Consider Plesiomonas shigelloides among rare causes

Diagnosis

The principal diagnostic method is:

Culture

For gastrointestinal disease, the organism can be recovered from:

Stool culture

For invasive disease, specimens depend on the affected site and may include:

• Blood

• Cerebrospinal fluid

• Joint fluid

• Wound or tissue specimens

• Other normally sterile fluids

Laboratory Identification

Laboratory identification is important because P. shigelloides may resemble other enteric Gram-negative organisms.

A useful characteristic is:

Oxidase positivity

This helps distinguish it from many members of the:

Enterobacterales

which are typically oxidase negative.

High-Yield Laboratory Pattern

Enteric-appearing Gram-negative bacillus

• ●

Oxidase positive

• ●

Freshwater association

• ●

Diarrheal illness

→ Think Plesiomonas shigelloides

Treatment

For uncomplicated gastroenteritis:

Antibiotics are usually unnecessary

because many infections are:

Mild and self-limited

The cornerstone of treatment is:

Fluid and electrolyte replacement

Rehydration

Management should focus on correcting losses caused by diarrhea.

This includes:

Oral rehydration

when tolerated.

More severe dehydration may require:

Intravenous fluid and electrolyte replacement

Antimicrobial Therapy

The source lists a:

Fluoroquinolone

as an antimicrobial treatment option.

Antibiotic therapy may be considered particularly for:

• Severe disease

• Persistent diarrhea

• Dysentery-like illness

• Significant systemic symptoms

• Invasive extraintestinal infection

Selection should be guided by the clinical syndrome and susceptibility information when available.

Additional Treatment Options

The source lists:

• Trimethoprim–sulfamethoxazole

• Chloramphenicol

• Carbapenems

• Aminoglycosides

For serious invasive infection, therapy should be selected according to:

Culture and antimicrobial susceptibility results

whenever possible.

Source Control

For focal invasive infections such as:

Septic arthritis

or

Deep soft tissue infection

antimicrobial therapy may need to be combined with:

Drainage or surgical source control

when clinically indicated.

Plesiomonas vs. Shigella

Despite the species name:

shigelloides

Plesiomonas shigelloides is not a Shigella species.

Plesiomonas shigelloides

→ Freshwater-associated

→ Oxidase positive

→ Motile

→ Can cause watery or bloody diarrhea

Shigella

→ Primarily human intestinal pathogen

→ Oxidase negative

→ Nonmotile

→ Characteristically causes inflammatory dysentery

Plesiomonas vs. Aeromonas

Both organisms may be associated with:

Freshwater

and can cause:

Gastrointestinal disease

Plesiomonas shigelloides

→ Diarrhea, including traveler’s diarrhea

→ Rare invasive infections

→ Neonatal meningitis is a notable severe manifestation

Aeromonas species

→ Freshwater exposure

→ Gastroenteritis

→ Particularly important in wound and soft tissue infections after water exposure

Plesiomonas vs. Vibrio

Plesiomonas

→ Classically associated with freshwater

→ Traveler’s diarrhea possible

Vibrio

→ Many clinically important species are strongly associated with marine or brackish water

→ Raw seafood exposure is an important epidemiologic clue for several species

Thus, the type of water exposure can help narrow the differential diagnosis.

Prevention

Prevention centers on reducing exposure to contaminated food and water.

Important measures include:

• Drinking safe water

• Appropriate food hygiene

• Properly cooking aquatic foods

• Careful food and water practices during travel

• Hand hygiene

High-Yield Clinical Pattern

Freshwater exposure

• ●

Short incubation of a few days

• ●

Traveler’s diarrhea

• ●

Watery or bloody diarrhea

• ●

Oxidase-positive Gram-negative bacillus

→ Think Plesiomonas shigelloides

Exam Essentials

Genus: Plesiomonas

Species: P. shigelloides

Type: Gram-negative bacillus

Metabolism: Facultatively anaerobic

Oxidase: Positive

Motility: Motile

Reservoir: Freshwater and soil

Incubation: Uncertain; probably a few days in many cases

Major disease: Gastroenteritis

Diarrhea: May range from mild watery disease to bloody inflammatory diarrhea

Stool finding in severe disease: Fecal leukocytes may occur

Travel association: Cause of traveler’s diarrhea

Rare infections: Bacteremia, skin/soft tissue infection, septic arthritis, osteomyelitis, cholecystitis, endophthalmitis, and meningitis

Important severe association: Neonatal meningitis

Diagnosis: Culture

Mild infection: Usually supportive treatment only

Essential therapy: Fluids and electrolytes

Source antimicrobial: Fluoroquinolone

Additional source agents: TMP-SMX, chloramphenicol, carbapenems, and aminoglycosides

Important laboratory clue: Oxidase positive, unlike typical Enterobacterales

Major environmental clue: Freshwater exposure

Key clinical pearl: Plesiomonas shigelloides is a freshwater-associated, oxidase-positive Gram-negative bacillus that primarily causes gastroenteritis, including traveler’s diarrhea. Most cases require only fluid and electrolyte replacement, but bloody inflammatory diarrhea can occur, and rare invasive infections—including particularly serious neonatal meningitis—should be recognized.

Click here to start customizing

Infectious Disease and Microbiology – Peptostreptococcus Species

Overview

Peptostreptococcus species are anaerobic Gram-positive cocci that form part of the normal human flora of the mouth, gastrointestinal tract, and female genital tract. They usually cause endogenous infections when normal mucosal barriers are disrupted and organisms enter normally sterile tissues.

They are especially important in polymicrobial infections, including intra-abdominal, pelvic, lung, and brain abscesses, but they may also cause bacteremia, surgical wound infection, skin and soft tissue infection, septic arthritis, and rarely endocarditis.

Classification

Genus: Peptostreptococcus

Species listed in the source include:

• P. anaerobius

• P. asaccharolyticus

• P. magnus

• P. prevotii

• Other species

Organism type: Anaerobic Gram-positive coccus

Taxonomy Note

The taxonomy of anaerobic Gram-positive cocci has changed substantially over time.

Some organisms historically classified as Peptostreptococcus have subsequently been moved into other genera. For example, organisms formerly known as:

Peptostreptococcus magnus

are now generally classified as:

Finegoldia magna

Therefore, older microbiology references may use names that differ from current laboratory terminology.

Microbiologic Characteristics

Peptostreptococcus species are:

• Gram-positive cocci

• Anaerobic

• Part of normal mucosal flora

• Usually involved in endogenous infections

• Frequently recovered together with other aerobic and anaerobic organisms

They are particularly associated with infections occurring in tissues with:

Low oxygen tension

and

Abscess formation

High-Yield Microbiology Pattern

Anaerobic Gram-positive coccus

• ●

Normal oral, bowel, or vaginal flora

• ●

Polymicrobial abscess

→ Think Peptostreptococcus

Incubation Period

A specific incubation period is generally not defined because infection usually results from:

Endogenous spread

rather than transmission from another person.

The organism is already present as part of the patient’s normal flora and becomes pathogenic after disruption of normal barriers.

Epidemiology

Peptostreptococcus species occur:

Worldwide

They normally colonize:

• Mouth and oropharynx

• Gastrointestinal tract

• Female genital tract

Because they are normal flora, the source of infection is usually:

The patient’s own microbiota

Pathogenesis

A typical sequence is:

Normal mucosal colonization

↓

Mucosal injury, surgery, aspiration, perforation, or tissue damage

↓

Organisms enter normally sterile tissue

↓

Low-oxygen environment develops

↓

Growth of anaerobic bacteria

↓

Polymicrobial infection and abscess formation

Polymicrobial Infection

Peptostreptococcus species are frequently isolated together with:

Aerobic bacteria

and

Other anaerobic bacteria

This is especially common in infections arising from:

• Oral flora

• Bowel flora

• Genital tract flora

Therefore, treatment often needs to cover:

Multiple bacterial groups

rather than Peptostreptococcus alone.

Intra-Abdominal Abscess

A major clinical setting is:

Intra-abdominal infection

Possible situations include:

• Bowel perforation

• Appendiceal disease

• Postoperative infection

• Intra-abdominal abscess formation

These infections are typically:

Polymicrobial

with combinations of enteric Gram-negative organisms and anaerobes.

High-Yield Pattern

GI source

• ●

Intra-abdominal abscess

• ●

Mixed aerobic/anaerobic culture

→ Consider Peptostreptococcus among the anaerobic organisms

Pelvic Infection

Peptostreptococcus may participate in:

Pelvic abscesses and polymicrobial pelvic infections

because it is part of the normal:

Female genital tract flora

Potential clinical settings include postoperative infection and other conditions that disrupt pelvic or genital tract barriers.

Lung Abscess

Because Peptostreptococcus can colonize the mouth and upper respiratory tract, aspiration may introduce these organisms into the lower respiratory tract.

This can contribute to:

Aspiration-associated pneumonia

and

Lung abscess

Anaerobic Pulmonary Pattern

Aspiration risk

• ●

Poor dentition/oral flora exposure

• ●

Necrotizing pneumonia or lung abscess

→ Think oral anaerobes, including Peptostreptococcus

Brain Abscess

Peptostreptococcus species can also occur in:

Brain abscesses

particularly when infection spreads from:

• Dental disease

• Sinus infection

• Otogenic infection

• Other contiguous sources

Brain abscesses can be polymicrobial, so appropriate anaerobic cultures are important.

Bacteremia

The organism may cause:

Bacteremia

especially when there is:

• A deep abscess

• Tissue necrosis

• Gastrointestinal or pelvic infection

• Significant mucosal disruption

Anaerobic bacteremia should prompt evaluation for an underlying deep infectious source.

Endocarditis

The source notes that Peptostreptococcus is a:

Rare cause of endocarditis

When endocarditis occurs, management may require:

• Prolonged antimicrobial therapy

• Blood cultures

• Echocardiographic evaluation

• Assessment for valvular complications

Skin and Soft Tissue Infection

Peptostreptococcus may contribute to:

Skin and soft tissue infections

especially when:

• Tissue oxygenation is poor

• Necrosis is present

• Infection is polymicrobial

• There is contamination from mucosal flora

Surgical Wound Infection

Postoperative wounds may become infected with mixed organisms, including:

Anaerobic Gram-positive cocci

particularly after procedures involving:

• Gastrointestinal tract

• Pelvic organs

• Contaminated tissue planes

Septic Arthritis

The source also lists:

Septic arthritis

as a possible manifestation.

This is uncommon but clinically significant because joint infection may require:

Joint drainage

plus

Appropriate antimicrobial therapy

Diagnosis

The primary diagnostic method is:

Culture under anaerobic conditions

Appropriate specimens include:

• Abscess aspirates

• Deep tissue samples

• Blood

• Joint fluid

• Normally sterile body fluids

Specimen Collection

Because these organisms are anaerobic:

Specimen quality and transport are critical

Whenever possible, obtain:

Deep aspirated material or tissue

rather than superficial swabs.

Specimens should be transported under:

Anaerobic conditions

to maximize recovery.

Interpretation of Culture

Because Peptostreptococcus species can be part of normal flora, interpretation depends on:

• Site of isolation

• Clinical syndrome

• Presence of an abscess

• Whether the specimen is from a sterile site

• Other organisms recovered

• Evidence of tissue invasion

Isolation from a properly obtained deep specimen in a compatible infection supports true pathogenicity.

Treatment

The source lists:

Penicillin G

as the principal treatment.

Historically, many anaerobic Gram-positive cocci have been susceptible to penicillin.

However, definitive treatment should consider:

Species identification

and

Antimicrobial susceptibility

when available.

Additional Treatment Options

The source lists:

• Clindamycin

• Cephamycins

• Carbapenems, including imipenem and meropenem

• Vancomycin

Because these infections are frequently polymicrobial, broader antimicrobial coverage may be required.

Broad-Spectrum Therapy

For serious polymicrobial infections, treatment may need activity against:

Anaerobes

• ●

Enteric Gram-negative bacilli

• ●

Gram-positive organisms

This is particularly relevant in:

• Intra-abdominal infection

• Pelvic infection

• Aspiration-associated lung abscess

• Necrotizing soft tissue infection

Source Control

A central treatment principle is:

ANTIBIOTICS

• ●

SOURCE CONTROL

Examples include:

• Drainage of abscesses

• Debridement of infected or necrotic tissue

• Joint drainage in septic arthritis

• Correction of perforation or other anatomic defects

• Management of infected surgical sites

High-Yield Treatment Principle

Anaerobic polymicrobial abscess

→ Appropriate antimicrobial therapy

AND

→ Drainage/source control when indicated

Peptostreptococcus vs. Peptococcus

Both are historically classified as:

Anaerobic Gram-positive cocci

and both may be part of:

Normal human flora

with disease characterized by:

• Endogenous infection

• Abscess formation

• Polymicrobial disease

A major distinction is taxonomic rather than a simple bedside clinical difference, and older sources may use these genera differently from current microbiology laboratories.

Peptostreptococcus vs. Staphylococcus aureus

Peptostreptococcus

→ Anaerobic

→ Normal mucosal flora

→ Often polymicrobial

→ Frequently associated with deep abscesses

Staphylococcus aureus

→ Facultative anaerobic Gram-positive coccus

→ Often a primary pathogen

→ Common cause of skin abscesses, bacteremia, endocarditis, and osteoarticular infection

Prevention

Because these infections are usually:

Endogenous

there is no specific vaccine or person-to-person avoidance strategy.

Prevention focuses on:

• Appropriate surgical technique

• Good oral hygiene

• Prompt management of perforation or tissue necrosis

• Proper wound care

• Prevention of aspiration in high-risk patients

• Early drainage of developing abscesses

High-Yield Clinical Pattern

Anaerobic Gram-positive cocci

• ●

Normal mouth, bowel, or vaginal flora

• ●

Polymicrobial infection

• ●

Abscess

→ Think Peptostreptococcus

High-Yield Site Pattern

Oral flora

→ Lung abscess / brain abscess

Bowel flora

→ Intra-abdominal abscess

Vaginal flora

→ Pelvic infection

This helps connect normal colonization sites with the likely infectious syndrome.

Exam Essentials

Genus: Peptostreptococcus

Source-listed species: P. anaerobius, P. asaccharolyticus, P. magnus, and P. prevotii

Type: Anaerobic Gram-positive coccus

Normal habitat: Mouth, gastrointestinal tract, and vagina

Distribution: Worldwide

Transmission: Usually endogenous

Major microbiologic setting: Polymicrobial infection

Major infections: Intra-abdominal, pelvic, lung, and brain abscesses

Other infections: Bacteremia, skin/soft tissue infection, surgical wound infection, septic arthritis, and rare endocarditis

Diagnosis: Anaerobic culture

Source treatment: Penicillin G

Additional source treatments: Clindamycin, cephamycin, imipenem, meropenem, and vancomycin

Major management principle: Treat the entire polymicrobial infection

Source control: Often essential for abscesses and septic arthritis

Taxonomy note: Some older Peptostreptococcus species have been reassigned to other genera

Key clinical pearl: Peptostreptococcus species are anaerobic Gram-positive cocci that normally inhabit the mouth, bowel, and female genital tract. They become pathogenic when normal barriers are disrupted and are most characteristic of endogenous polymicrobial abscesses—especially intra-abdominal, pelvic, lung, and brain abscesses—where successful management often requires both appropriate anaerobic antimicrobial coverage and source control.

Infectious Disease and Microbiology – Penicillium Species

Overview

Penicillium species are filamentous fungi (molds) characterized by septate, hyaline hyphae. They are widespread environmental organisms and historically were often considered laboratory contaminants when recovered from clinical specimens. However, several species can cause genuine human disease, particularly in susceptible or immunocompromised patients.

Of particular historical importance is Penicillium marneffei, now classified as Talaromyces marneffei. It causes talaromycosis, an important systemic fungal infection in parts of South and Southeast Asia, especially among immunocompromised individuals.

⸻

Classification

Genus: Penicillium

Species listed in the source include:

• P. chrysogenum

• P. commune

• P. marneffei

• Other species

Organism type: Filamentous fungus (mold)

⸻

Important Taxonomy Update

The organism historically known as:

Penicillium marneffei

has been reclassified as:

Talaromyces marneffei

Therefore:

Old name: Penicillium marneffei

→

Current name: Talaromyces marneffei

The disease is now generally called:

Talaromycosis

rather than penicilliosis.

⸻

Microbiologic Characteristics

Most Penicillium species demonstrate:

• Filamentous fungal growth

• Septate hyaline hyphae

• Branched conidiophores

• Chains of conidia

• Characteristic brush-like microscopic structures

The name Penicillium derives from the brush-like appearance of its conidiophores.

⸻

Classic Morphology

Septate hyaline hyphae

Brush-like conidiophores

→ Think Penicillium

This morphology can resemble other environmental hyaline molds.

⸻

Talaromyces marneffei – Important Exception

Talaromyces marneffei is particularly important because it is a:

Thermally dimorphic fungus

rather than behaving solely as a typical environmental mold.

A simplified pattern is:

Environment / lower temperature

→ Mold form

Human tissue / body temperature

→ Yeast-like form

This feature distinguishes it from many ordinary Penicillium species.

⸻

High-Yield Microbiology Pattern

Formerly Penicillium marneffei

Thermally dimorphic fungus

Southeast Asia

Immunocompromised patient

Disseminated infection

→ Think Talaromyces marneffei

⸻

Incubation Period

The incubation period is:

Unknown

Disease may occur after environmental acquisition, particularly when host immunity is impaired.

⸻

Epidemiology

Penicillium species occur:

Worldwide

as common environmental molds.

However, the source particularly emphasizes P. marneffei—now T. marneffei—as an important pathogen in the:

Far East / Southeast Asia

⸻

Geographic Association of Talaromyces marneffei

T. marneffei is endemic in parts of:

South and Southeast Asia

and southern China.

This geographic association is an important diagnostic clue when disseminated fungal disease develops in an immunocompromised patient with relevant residence or travel history.

⸻

Environmental Exposure

Penicillium species are widespread in:

• Soil

• Decaying vegetation

• Organic material

• Indoor and outdoor environments

Because they are common environmental molds, their isolation from a nonsterile clinical specimen does not automatically establish invasive infection.

⸻

Contaminant vs. True Pathogen

A major clinical challenge is determining whether a Penicillium isolate represents:

Environmental contamination

or

TRUE INFECTION

⸻

Evidence Supporting True Infection

True pathogenicity becomes more likely when there is:

• Isolation from a normally sterile site

• Repeated recovery of the same organism

• Compatible clinical disease

• Histopathologic evidence of fungal invasion

• Immunocompromised host

• Compatible radiographic abnormalities

• Relevant geographic exposure

⸻

Talaromycosis

Talaromyces marneffei causes:

Talaromycosis

This is an important:

Systemic and disseminated fungal infection

especially in patients with impaired cell-mediated immunity.

⸻

Association with HIV/AIDS

Historically, T. marneffei became particularly recognized as an opportunistic infection among patients with:

Advanced HIV/AIDS

in endemic regions of Asia.

Disseminated disease can be severe and potentially fatal without appropriate antifungal therapy.

⸻

High-Yield Clinical Pattern

Advanced immunosuppression

Residence/travel in Southeast Asia

Disseminated fungal infection

→ Think Talaromyces marneffei

⸻

Disseminated Talaromycosis

Disseminated infection may involve multiple organ systems.

Possible manifestations include:

• Fever

• Weight loss

• Fatigue

• Lymphadenopathy

• Hepatosplenomegaly

• Respiratory manifestations

• Skin lesions

• Anemia or other hematologic abnormalities

⸻

Skin Lesions

Cutaneous manifestations are an important clue in disseminated talaromycosis.

Patients may develop:

Papular skin lesions

Some lesions can demonstrate:

Central umbilication

This can create an appearance resembling:

Molluscum contagiosum

particularly in patients with advanced HIV infection.

⸻

High-Yield Skin Pattern

Immunocompromised patient from Southeast Asia

Fever and systemic illness

Umbilicated papular skin lesions

→ Consider Talaromyces marneffei

⸻

Respiratory Tract Infection

Penicillium species can cause:

Respiratory tract infection

although distinguishing colonization from invasive disease is important.

Pulmonary manifestations may include:

• Cough

• Fever

• Dyspnea

• Pulmonary infiltrates

Immunocompromised patients are at greater risk for invasive fungal disease.

⸻

Endocarditis

The source reports:

Endocarditis

as a possible manifestation of Penicillium infection.

Fungal endocarditis is uncommon but serious and may require:

Prolonged systemic antifungal therapy

plus consideration of:

Surgical management

depending on the clinical situation.

⸻

Keratitis

Penicillium species may cause:

Fungal keratitis

Possible manifestations include:

• Eye pain

• Redness

• Photophobia

• Reduced vision

• Corneal ulceration

Culture and appropriate ophthalmologic evaluation are important.

⸻

Otitis Externa

Another reported manifestation is:

Otitis externa

Environmental molds can colonize or infect the external auditory canal under appropriate conditions.

⸻

Urinary Tract Infection

The source also lists:

Urinary tract infection

as a possible manifestation.

Because Penicillium is an environmental organism, isolation from urine should be interpreted together with symptoms, repeat cultures, host factors, and evidence of true infection.

⸻

Diagnosis

The principal diagnostic methods are:

Culture

and

Tissue biopsy

⸻

Culture

Fungal culture can establish the organism’s identity.

However, because many Penicillium species are common environmental contaminants:

Culture positivity alone may not prove invasive infection.

The clinical context is essential.

⸻

Tissue Biopsy

Biopsy can be particularly valuable for establishing:

Tissue invasion

Histopathologic examination may demonstrate fungal elements within affected tissue and help distinguish:

True invasive infection

from:

Environmental contamination

⸻

Diagnosis of Talaromycosis

Depending on the site of disease, diagnostic specimens may include:

• Blood

• Skin lesion material

• Bone marrow

• Lymph-node tissue

• Respiratory specimens

• Other involved tissues

Culture and histopathology are important diagnostic approaches.

⸻

Treatment

The source recommends:

Intravenous amphotericin B

for:

Severe Penicillium infections

This is particularly relevant to severe invasive or disseminated fungal disease.

⸻

Itraconazole

The source also identifies:

Itraconazole

as an effective antifungal agent.

For systemic infection, therapy is generally prolonged and should be tailored to:

• Species

• Severity

• Site of infection

• Host immune status

• Antifungal susceptibility when relevant

⸻

Treatment of Severe Talaromycosis

A useful general treatment concept for severe disseminated talaromycosis is:

Initial amphotericin-based therapy

↓

Clinical stabilization

↓

Itraconazole consolidation therapy

↓

Prolonged treatment and management of the underlying immunosuppression

Exact regimens should follow current disease-specific recommendations.

⸻

Immune Restoration

For talaromycosis associated with HIV infection, antifungal therapy should be accompanied by appropriate management of the underlying:

HIV infection and immune suppression

because restoration of immune function is important for preventing recurrence.

⸻

Penicillium vs. Paecilomyces

Penicillium

→ Environmental mold

→ Septate hyaline hyphae

→ Brush-like conidiophores

→ Frequently represents environmental contamination

→ Some species cause invasive disease

Paecilomyces

→ Environmental hyaline mold

→ Can resemble Penicillium

→ Opportunistic infection

→ Particularly associated with keratitis, endophthalmitis, and invasive infection in susceptible hosts

⸻

Talaromyces marneffei vs. Histoplasma

Talaromyces marneffei

→ South/Southeast Asia

→ Advanced immunosuppression/HIV association

→ Disseminated infection

→ Skin papules may show central umbilication

Histoplasma capsulatum

→ Various endemic regions, especially the Americas

→ Soil enriched with bird/bat droppings

→ Small intracellular yeast

→ Disseminated disease particularly in immunocompromised patients

The two infections can resemble one another clinically and histopathologically.

⸻

Important Morphologic Distinction

T. marneffei yeast-like cells characteristically reproduce by:

Fission

rather than typical budding.

A characteristic finding is a:

Transverse septum

within dividing yeast-like cells.

⸻

High-Yield Morphology Pattern

Yeast-like cells

Central/transverse septum

Division by fission

Southeast Asian exposure

→ Talaromyces marneffei

⸻

High-Yield Clinical Pattern

Patient with advanced HIV/immunosuppression

South or Southeast Asian exposure

Fever + weight loss + lymphadenopathy

Disseminated fungal disease

Umbilicated skin papules

→ Think Talaromyces marneffei

⸻

Exam Essentials

Genus: Penicillium

Organism type: Filamentous fungus/mold

Hyphae: Septate and hyaline

Characteristic mold morphology: Brush-like conidiophores

Incubation: Unknown

Distribution: Environmental Penicillium species occur worldwide

Traditional interpretation: Frequently considered contaminants

Pathogenicity: Some species can cause true opportunistic infection

Source-listed infections: Endocarditis, keratitis, otitis externa, respiratory infection, and urinary infection

Diagnosis: Culture + tissue biopsy/histopathology

Severe invasive infection: Source recommends IV amphotericin B

Additional source treatment: Itraconazole

Former P. marneffei: Now Talaromyces marneffei

Disease: Talaromycosis

Type: Thermally dimorphic fungus

Geography: South and Southeast Asia/southern China

Major risk group: Immunocompromised patients, historically especially advanced HIV/AIDS

Major manifestation: Disseminated infection

Characteristic skin clue: Umbilicated papules

Characteristic tissue morphology: Fission with a transverse septum

Severe talaromycosis: Amphotericin-based induction followed by prolonged oral antifungal therapy is an important treatment concept

⸻

Key clinical pearl: Most Penicillium species encountered clinically may represent environmental contamination, so true infection should be supported by the clinical setting, repeated or sterile-site isolation, or tissue invasion. The major exception to remember is former Penicillium marneffei, now Talaromyces marneffei: a thermally dimorphic fungus endemic in South and Southeast Asia that can cause severe disseminated disease in immunocompromised patients, classically with fever, systemic illness, and umbilicated skin lesions.

Infectious Disease and Microbiology – Pediococcus Species

Overview

Pediococcus species are Gram-positive cocci that are widely distributed in the environment and are generally considered organisms of low pathogenicity. Historically, their recovery from clinical specimens was often interpreted as contamination or colonization. However, Pediococcus can cause true opportunistic infection, particularly in immunocompromised or seriously ill patients.

The most important reported clinical manifestation is bacteremia, although respiratory tract infections and other invasive infections may occur.

Classification

Genus: Pediococcus

Important species include:

• Pediococcus acidilactici

• Pediococcus pentosaceus

Organism type: Gram-positive coccus

Microbiologic Characteristics

Pediococcus species are:

• Gram-positive cocci

• Catalase-negative

• Lactic acid-producing bacteria

• Usually arranged in pairs, tetrads, or clusters

• Capable of being confused with other catalase-negative Gram-positive cocci

A particularly important laboratory consideration is their resemblance to:

Leuconostoc species.

Characteristic Arrangement

A useful morphologic clue is the tendency of Pediococcus to divide in:

Two perpendicular planes

This can produce characteristic:

Tetrads

on microscopic examination.

High-Yield Microbiology Pattern

Gram-positive cocci

• ●

Catalase-negative

• ●

Tetrad formation

• ●

May resemble Leuconostoc

→ Think Pediococcus

Intrinsic Vancomycin Resistance

One of the most clinically important characteristics of Pediococcus is:

Intrinsic resistance to vancomycin

This characteristic is particularly useful because the organism may initially be mistaken for other Gram-positive cocci for which vancomycin would ordinarily be considered.

Therefore:

Gram-positive coccus + vancomycin resistance

should raise consideration of organisms such as:

Pediococcus or Leuconostoc.

High-Yield Resistance Pattern

Catalase-negative Gram-positive coccus

• ●

Unexpected vancomycin resistance

→ Consider:

Pediococcus

or

Leuconostoc

Incubation Period

The incubation period for Pediococcus infection is:

Unknown

Because most disease is opportunistic rather than a characteristic acute transmissible syndrome, a specific incubation period is generally difficult to define.

Epidemiology

Pediococcus species have a:

Worldwide distribution

They occur naturally in environmental and food-related settings and are associated with fermentation processes.

Human invasive disease remains:

Rare

Opportunistic Infection

Historically, isolation of Pediococcus from clinical specimens was often dismissed as:

Contamination

However, the organism has increasingly been recognized as a potential:

Opportunistic pathogen

True infection is particularly important to consider in:

• Immunocompromised patients

• Seriously ill hospitalized patients

• Patients with invasive devices

• Patients with repeated positive cultures

• Patients with compatible signs of systemic infection

Contaminant vs. True Pathogen

When Pediococcus is recovered from a clinical specimen, interpretation requires clinical correlation.

Evidence favoring:

TRUE INFECTION

includes:

• Repeated positive blood cultures

• Isolation from a normally sterile site

• Compatible fever or sepsis

• Immunocompromised host

• Presence of an invasive device

• Clinical improvement with appropriate therapy

A single isolate without compatible clinical disease may be less convincing.

Bacteremia

The most important invasive manifestation described in the source is:

Bacteremia

Patients may develop:

• Fever

• Chills

• Malaise

• Hypotension in severe infection

• Other manifestations of systemic infection

Because Pediococcus was traditionally regarded as a contaminant, recognizing true bloodstream infection is particularly important.

High-Yield Clinical Pattern

Immunocompromised patient

• ●

Positive blood cultures for Gram-positive cocci

• ●

Vancomycin resistance

• ●

Pediococcus identified

→ Consider true Pediococcus bacteremia

rather than automatically dismissing the isolate as contamination.

Respiratory Tract Infection

The source also reports:

Respiratory tract infections

associated with Pediococcus species.

These infections are uncommon and should be interpreted in conjunction with:

• Respiratory symptoms

• Imaging findings

• Quality of respiratory specimen

• Host immune status

• Evidence of systemic infection

Because Pediococcus can represent colonization or contamination, isolation alone does not always establish pulmonary disease.

Other Invasive Infections

Although uncommon, Pediococcus species have also been reported in other invasive clinical settings.

The clinical significance is greatest when the organism is:

Repeatedly isolated

or recovered from a:

Normally sterile site

in a patient with compatible disease.

Diagnosis

The primary diagnostic method is:

Culture

Possible specimens include:

• Blood

• Respiratory specimens

• Other normally sterile fluids or tissues

Accurate laboratory identification is important because Pediococcus may be mistaken for other Gram-positive organisms.

Laboratory Identification

Important characteristics include:

Gram-positive cocci

• ●

Catalase negative

• ●

Tetrad formation

• ●

Intrinsic vancomycin resistance

These features can help distinguish Pediococcus from more common Gram-positive cocci.

Pediococcus vs. Leuconostoc

These organisms can resemble each other microbiologically.

Pediococcus

→ Gram-positive cocci

→ Catalase-negative

→ Often forms tetrads

→ Intrinsically vancomycin resistant

Leuconostoc

→ Gram-positive coccoid organism

→ Catalase-negative

→ May resemble streptococci/enterococci

→ Intrinsically vancomycin resistant

Therefore, accurate species-level identification may require appropriate biochemical or modern laboratory identification methods.

Pediococcus vs. Enterococcus

Pediococcus

→ Rare opportunistic pathogen

→ Tetrad formation may occur

→ Intrinsic vancomycin resistance

Enterococcus

→ Much more common human pathogen

→ UTI, bacteremia, endocarditis, intra-abdominal infection

→ Vancomycin susceptibility varies; resistance may be acquired through resistance mechanisms such as VanA or VanB

Important Exam Distinction

Pediococcus

→ Vancomycin resistance is intrinsic

Vancomycin-resistant Enterococcus (VRE)

→ Resistance is generally acquired

Treatment

The source lists:

Penicillin G

and

Ampicillin

as treatment options.

Treatment should ideally be guided by:

Antimicrobial susceptibility testing

because clinically significant Pediococcus infection is uncommon and susceptibility patterns may vary.

Daptomycin

The source also lists:

Daptomycin

as an important treatment option.

This may be particularly relevant for serious bloodstream infection when susceptibility and clinical circumstances support its use.

Additional Treatment

Additional agents listed in the source include:

• Aminoglycosides

• Imipenem

Choice of antimicrobial therapy should depend on:

• Susceptibility results

• Site of infection

• Severity of illness

• Host immune status

• Presence of an infected device or other source

Vancomycin

An especially important treatment principle is:

Do not assume vancomycin will treat Pediococcus.

Pediococcus species are characteristically:

Intrinsically resistant to vancomycin

Thus, recognition of the organism can have immediate therapeutic implications.

Source Control

When bacteremia is associated with:

An invasive device

appropriate source control should be considered.

Management of true invasive infection therefore involves:

Active antimicrobial therapy

• ●

Identification and control of the infectious source

when possible.

High-Yield Treatment Pattern

Pediococcus bacteremia

• ●

Intrinsic vancomycin resistance

→ Consider a susceptible agent such as:

Penicillin / ampicillin

or

Daptomycin

with definitive treatment based on susceptibility testing and the clinical syndrome.

Clinical Significance

The major challenge with Pediococcus is determining whether an isolate represents:

CONTAMINATION

or

TRUE OPPORTUNISTIC INFECTION

In an immunocompromised patient with repeated positive blood cultures and systemic signs of infection, Pediococcus should not automatically be dismissed as a contaminant.

High-Yield Clinical Pattern

Immunocompromised patient

• ●

Bacteremia

• ●

Catalase-negative Gram-positive coccus

• ●

Tetrad arrangement

• ●

Vancomycin resistance

→ Think Pediococcus

Exam Essentials

Genus: Pediococcus

Important species: P. acidilactici and P. pentosaceus

Type: Gram-positive coccus

Catalase: Negative

Characteristic arrangement: Pairs/tetrads, with tetrads being a useful clue

Distribution: Worldwide

Incubation: Unknown

Pathogenicity: Rare opportunistic pathogen

Historical interpretation: Often considered a contaminant

Important host: Immunocompromised patient

Major infection: Bacteremia

Other source-listed infection: Respiratory tract infection

Diagnosis: Culture

Important differential: Leuconostoc

Major resistance clue: Intrinsic vancomycin resistance

Source treatment: Penicillin G, ampicillin, or daptomycin

Additional source treatments: Aminoglycoside or imipenem

Treatment principle: Use susceptibility-guided therapy for clinically significant infection

Source control: Consider when an invasive device or another removable focus is implicated

Key clinical pearl: Pediococcus is a rare opportunistic Gram-positive coccus that can be mistaken for Leuconostoc or dismissed as a contaminant. In an immunocompromised patient with genuine bacteremia, the major high-yield clue is its intrinsic resistance to vancomycin; penicillin/ampicillin or daptomycin may be useful when susceptibility and the clinical situation support their use.